[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fIaVfrdRX722CGlb5B20CEM3ksKfB7ksneKwDE3EfBdA":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":42,"rows":49},"University Hospital Hradec Kralove",[4],44,false,10,1,6522,2,32,[14,17,19,21,23,25,27,29],{"name":15,"count":16},"Anesthesia",3,{"name":18,"count":11},"Hydrocephalus",{"name":20,"count":11},"Brain Damage",{"name":22,"count":11},"Mild Cognitive Impairment",{"name":24,"count":11},"Sepsis",{"name":26,"count":11},"Endothelial Dysfunction",{"name":28,"count":11},"Critical Illness",{"name":30,"count":9},"Covid19",[32,37],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT05606536","The Impact of Intra-operative Fluid Infusion Rate on Microcirculation","2025-12-31","Crystalloid Solutions",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT07415655","Modulation of Cerebral Ischemia by Albumin","2027-02-01","Albumin",[43,44,45,46,47,48],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[50,74,97,125,143,171,189,214,240,265,283,308,326,353,371,389,416,439],{"intervention":41,"totalTrials":9,"cells":51},{"EARLY_PHASE1":52,"PHASE1":55,"PHASE2":57,"PHASE3":68,"PHASE4":70,"NA":72},{"trials":53,"activeCount":54},[],0,{"trials":56,"activeCount":54},[],{"trials":58,"activeCount":9,"soonestReadout":40},[59],{"nctId":38,"briefTitle":39,"status":60,"phases":61,"primaryCompletion":40,"completion":62,"start":63,"enrollment":64,"conditions":65,"interventions":67},"RECRUITING",[45],"2028-02-01","2026-02-03",100,[66],"Ischemic Stroke",[41],{"trials":69,"activeCount":54},[],{"trials":71,"activeCount":54},[],{"trials":73,"activeCount":54},[],{"intervention":36,"totalTrials":9,"cells":75},{"EARLY_PHASE1":76,"PHASE1":78,"PHASE2":80,"PHASE3":82,"PHASE4":84,"NA":86},{"trials":77,"activeCount":54},[],{"trials":79,"activeCount":54},[],{"trials":81,"activeCount":54},[],{"trials":83,"activeCount":54},[],{"trials":85,"activeCount":54},[],{"trials":87,"activeCount":9,"soonestReadout":35},[88],{"nctId":33,"briefTitle":34,"status":60,"phases":89,"primaryCompletion":35,"completion":35,"start":90,"enrollment":91,"conditions":92,"interventions":96},[48],"2022-10-01",80,[93,94,95],"Fluid Therapy","Microcirculation","Hemodilution",[36],{"intervention":98,"totalTrials":9,"cells":99},"Tranexamic Acid Injectable Product",{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":108,"NA":123},{"trials":101,"activeCount":54},[],{"trials":103,"activeCount":54},[],{"trials":105,"activeCount":54},[],{"trials":107,"activeCount":54},[],{"trials":109,"activeCount":54},[110],{"nctId":111,"briefTitle":112,"status":113,"phases":114,"primaryCompletion":115,"completion":116,"start":117,"enrollment":118,"conditions":119,"interventions":121},"NCT04319614","Can the Prophylactic Administration of Tranexamic Acid Reduce Blood Loss After Robotic-assisted Radical Prostatectomy?","COMPLETED",[47],"2022-02-12","2022-06-30","2020-02-24",200,[120],"Robotic-assisted Radical Prostatectomy",[98,122],"Placebos",{"trials":124,"activeCount":54},[],{"intervention":122,"totalTrials":9,"cells":126},{"EARLY_PHASE1":127,"PHASE1":129,"PHASE2":131,"PHASE3":133,"PHASE4":135,"NA":141},{"trials":128,"activeCount":54},[],{"trials":130,"activeCount":54},[],{"trials":132,"activeCount":54},[],{"trials":134,"activeCount":54},[],{"trials":136,"activeCount":54},[137],{"nctId":111,"briefTitle":112,"status":113,"phases":138,"primaryCompletion":115,"completion":116,"start":117,"enrollment":118,"conditions":139,"interventions":140},[47],[120],[98,122],{"trials":142,"activeCount":54},[],{"intervention":144,"totalTrials":9,"cells":145},"Furosemide 40 mg",{"EARLY_PHASE1":146,"PHASE1":148,"PHASE2":150,"PHASE3":152,"PHASE4":167,"NA":169},{"trials":147,"activeCount":54},[],{"trials":149,"activeCount":54},[],{"trials":151,"activeCount":54},[],{"trials":153,"activeCount":54},[154],{"nctId":155,"briefTitle":156,"status":157,"phases":158,"primaryCompletion":159,"completion":160,"start":161,"enrollment":162,"conditions":163,"interventions":165},"NCT06252454","The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases","UNKNOWN",[45,46],"2024-12","2025-12","2024-02-27",102,[164],"Dyspnea",[144,166],"Levodropropizine",{"trials":168,"activeCount":54},[],{"trials":170,"activeCount":54},[],{"intervention":166,"totalTrials":9,"cells":172},{"EARLY_PHASE1":173,"PHASE1":175,"PHASE2":177,"PHASE3":179,"PHASE4":185,"NA":187},{"trials":174,"activeCount":54},[],{"trials":176,"activeCount":54},[],{"trials":178,"activeCount":54},[],{"trials":180,"activeCount":54},[181],{"nctId":155,"briefTitle":156,"status":157,"phases":182,"primaryCompletion":159,"completion":160,"start":161,"enrollment":162,"conditions":183,"interventions":184},[45,46],[164],[144,166],{"trials":186,"activeCount":54},[],{"trials":188,"activeCount":54},[],{"intervention":190,"totalTrials":9,"cells":191},"Nivolumab",{"EARLY_PHASE1":192,"PHASE1":194,"PHASE2":196,"PHASE3":208,"PHASE4":210,"NA":212},{"trials":193,"activeCount":54},[],{"trials":195,"activeCount":54},[],{"trials":197,"activeCount":54},[198],{"nctId":199,"briefTitle":200,"status":113,"phases":201,"primaryCompletion":202,"completion":202,"start":203,"enrollment":204,"conditions":205,"interventions":207},"NCT04098432","STR + Anti PD-1 Therapy in Patients with Locally Advanced Unresectable Pancreatic Adenocarcinoma",[44,45],"2022-09-30","2018-12-03",15,[206],"Locally Advanced Unresectable Pancreatic Adenocarcinoma",[190],{"trials":209,"activeCount":54},[],{"trials":211,"activeCount":54},[],{"trials":213,"activeCount":54},[],{"intervention":215,"totalTrials":9,"cells":216},"Combined prandial insulin therapy",{"EARLY_PHASE1":217,"PHASE1":219,"PHASE2":221,"PHASE3":223,"PHASE4":225,"NA":227},{"trials":218,"activeCount":54},[],{"trials":220,"activeCount":54},[],{"trials":222,"activeCount":54},[],{"trials":224,"activeCount":54},[],{"trials":226,"activeCount":54},[],{"trials":228,"activeCount":54},[229],{"nctId":230,"briefTitle":231,"status":157,"phases":232,"primaryCompletion":233,"completion":234,"start":235,"enrollment":236,"conditions":237,"interventions":239},"NCT01088451","Joint Application of Human Insulin and Rapid Insulin Analogue in Control of Postprandial Glycemia",[48],"2010-03","2010-09","2009-12",20,[238],"Diabetes Mellitus, Type 1",[215],{"intervention":241,"totalTrials":9,"cells":242},"Nimodipine group",{"EARLY_PHASE1":243,"PHASE1":245,"PHASE2":247,"PHASE3":249,"PHASE4":251,"NA":253},{"trials":244,"activeCount":54},[],{"trials":246,"activeCount":54},[],{"trials":248,"activeCount":54},[],{"trials":250,"activeCount":54},[],{"trials":252,"activeCount":54},[],{"trials":254,"activeCount":54},[255],{"nctId":256,"briefTitle":257,"status":258,"phases":259,"primaryCompletion":260,"completion":260,"start":261,"enrollment":204,"conditions":262,"interventions":263},"NCT02537080","The Effect of Nimodipine on the Postoperative Cognitive Dysfunction","TERMINATED",[48],"2017-12","2015-09",[22],[241,264],"Control group",{"intervention":264,"totalTrials":9,"cells":266},{"EARLY_PHASE1":267,"PHASE1":269,"PHASE2":271,"PHASE3":273,"PHASE4":275,"NA":277},{"trials":268,"activeCount":54},[],{"trials":270,"activeCount":54},[],{"trials":272,"activeCount":54},[],{"trials":274,"activeCount":54},[],{"trials":276,"activeCount":54},[],{"trials":278,"activeCount":54},[279],{"nctId":256,"briefTitle":257,"status":258,"phases":280,"primaryCompletion":260,"completion":260,"start":261,"enrollment":204,"conditions":281,"interventions":282},[48],[22],[241,264],{"intervention":284,"totalTrials":9,"cells":285},"desflurane - oxygen in air",{"EARLY_PHASE1":286,"PHASE1":288,"PHASE2":290,"PHASE3":292,"PHASE4":294,"NA":296},{"trials":287,"activeCount":54},[],{"trials":289,"activeCount":54},[],{"trials":291,"activeCount":54},[],{"trials":293,"activeCount":54},[],{"trials":295,"activeCount":54},[],{"trials":297,"activeCount":54},[298],{"nctId":299,"briefTitle":300,"status":113,"phases":301,"primaryCompletion":302,"completion":302,"start":303,"enrollment":91,"conditions":304,"interventions":306},"NCT02617680","Factors Affecting the Effective End-tidal Concentration of Desflurane Anaesthesia",[48],"2015-12","2015-02",[305],"General Anesthetic Drug Adverse Reaction",[284,307],"desflurane - oxygen in nitric oxide",{"intervention":307,"totalTrials":9,"cells":309},{"EARLY_PHASE1":310,"PHASE1":312,"PHASE2":314,"PHASE3":316,"PHASE4":318,"NA":320},{"trials":311,"activeCount":54},[],{"trials":313,"activeCount":54},[],{"trials":315,"activeCount":54},[],{"trials":317,"activeCount":54},[],{"trials":319,"activeCount":54},[],{"trials":321,"activeCount":54},[322],{"nctId":299,"briefTitle":300,"status":113,"phases":323,"primaryCompletion":302,"completion":302,"start":303,"enrollment":91,"conditions":324,"interventions":325},[48],[305],[284,307],{"intervention":327,"totalTrials":9,"cells":328},"Sufentanil SPI analgesia",{"EARLY_PHASE1":329,"PHASE1":331,"PHASE2":333,"PHASE3":335,"PHASE4":337,"NA":339},{"trials":330,"activeCount":54},[],{"trials":332,"activeCount":54},[],{"trials":334,"activeCount":54},[],{"trials":336,"activeCount":54},[],{"trials":338,"activeCount":54},[],{"trials":340,"activeCount":54},[341],{"nctId":342,"briefTitle":343,"status":113,"phases":344,"primaryCompletion":345,"completion":346,"start":347,"enrollment":348,"conditions":349,"interventions":350},"NCT02490540","ANI and SPI Guided Intraoperative Analgesia",[48],"2015-10","2015-11","2015-06",72,[15],[327,351,352],"Sufentanil ANI analgesia","Sufentanil anesthesiologist analgesia",{"intervention":351,"totalTrials":9,"cells":354},{"EARLY_PHASE1":355,"PHASE1":357,"PHASE2":359,"PHASE3":361,"PHASE4":363,"NA":365},{"trials":356,"activeCount":54},[],{"trials":358,"activeCount":54},[],{"trials":360,"activeCount":54},[],{"trials":362,"activeCount":54},[],{"trials":364,"activeCount":54},[],{"trials":366,"activeCount":54},[367],{"nctId":342,"briefTitle":343,"status":113,"phases":368,"primaryCompletion":345,"completion":346,"start":347,"enrollment":348,"conditions":369,"interventions":370},[48],[15],[327,351,352],{"intervention":352,"totalTrials":9,"cells":372},{"EARLY_PHASE1":373,"PHASE1":375,"PHASE2":377,"PHASE3":379,"PHASE4":381,"NA":383},{"trials":374,"activeCount":54},[],{"trials":376,"activeCount":54},[],{"trials":378,"activeCount":54},[],{"trials":380,"activeCount":54},[],{"trials":382,"activeCount":54},[],{"trials":384,"activeCount":54},[385],{"nctId":342,"briefTitle":343,"status":113,"phases":386,"primaryCompletion":345,"completion":346,"start":347,"enrollment":348,"conditions":387,"interventions":388},[48],[15],[327,351,352],{"intervention":390,"totalTrials":9,"cells":391},"Fluid bolus administration",{"EARLY_PHASE1":392,"PHASE1":394,"PHASE2":396,"PHASE3":398,"PHASE4":400,"NA":402},{"trials":393,"activeCount":54},[],{"trials":395,"activeCount":54},[],{"trials":397,"activeCount":54},[],{"trials":399,"activeCount":54},[],{"trials":401,"activeCount":54},[],{"trials":403,"activeCount":54},[404],{"nctId":405,"briefTitle":406,"status":113,"phases":407,"primaryCompletion":408,"completion":409,"start":410,"enrollment":411,"conditions":412,"interventions":415},"NCT03891342","Effect of Fluid Challenge on Glycocalyx",[48],"2018-07","2018-08","2016-02",120,[15,26,24,413,414],"Septic Shock","Surgery",[390],{"intervention":417,"totalTrials":9,"cells":418},"Meropenem",{"EARLY_PHASE1":419,"PHASE1":421,"PHASE2":423,"PHASE3":425,"PHASE4":427,"NA":429},{"trials":420,"activeCount":54},[],{"trials":422,"activeCount":54},[],{"trials":424,"activeCount":54},[],{"trials":426,"activeCount":54},[],{"trials":428,"activeCount":54},[],{"trials":430,"activeCount":54},[431],{"nctId":432,"briefTitle":433,"status":113,"phases":434,"primaryCompletion":435,"completion":435,"start":436,"enrollment":236,"conditions":437,"interventions":438},"NCT03136796","Glycocalyx Damage and Beta-lactam Antibiotics in Surgical Critically Ill",[],"2018-09-30","2017-05-02",[28],[417],{"intervention":440,"totalTrials":9,"cells":441},"Vaccionation eighter started or full course",{"EARLY_PHASE1":442,"PHASE1":444,"PHASE2":446,"PHASE3":448,"PHASE4":450,"NA":452},{"trials":443,"activeCount":54},[],{"trials":445,"activeCount":54},[],{"trials":447,"activeCount":54},[],{"trials":449,"activeCount":54},[],{"trials":451,"activeCount":54},[],{"trials":453,"activeCount":54},[454],{"nctId":455,"briefTitle":456,"status":113,"phases":457,"primaryCompletion":458,"completion":458,"start":459,"enrollment":460,"conditions":461,"interventions":466},"NCT05589233","COVID-19 Vaccination AZV 2021-2023",[],"2023-11-30","2021-01-01",3000,[462,463,464,465],"COVID-19","Vaccination","Immunity","Respiratory Failure",[440]]